ÌÇÐÄÆƽâ°æ

Book value per share of GSK Pharmaceuticals Limited across India from financial year 2015 to 2026 (in Indian rupees)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2026

Region

India

Survey time period

FY 2015 to FY 2026

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2026 started in April 2025 and ended in March 2026. 

One Indian rupee is equal to 0.009 euros and 0.010 U.S. dollars (as of July 2026).  

Citation formats

GSK Pharmaceuticals' book value per share India FY 2015-2026

Published by A. Minhas, Jul 21, 2026

In financial year 2026, the book value per share for GSK Pharmaceuticals Limited stood at *** Indian rupees. This marked a slight increase in the book value for GSK shares compared to the previous year. In financial year 2025, GSK ranked as the leading brand in the private vaccine market and the dermatology segment.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

GSK (GlaxoSmithKline)SanofiAstraZenecaPharmaceutical industry in the UKVaccine-preventable diseases in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.